👥 HR & Workplace🇮🇳 India
US Faces Cancer Drug Shortage, Turns to Indian Manufacturers for Help
mint - companies·Tuesday, 23 June 2026
The US FDA is reaching out to Indian drugmakers to secure supplies of ifosfamide, a cancer treatment facing a shortage due to manufacturing disruptions. India's drug manufacturers' body, IDMA, is gathering information on which Indian companies can supply the medicine. Firms like Alkem Laboratories and GLS Pharma are among those being looked at.
Why It Matters
This is a direct opportunity for India's pharmaceutical industry, which is already a major global supplier of generic medicines, to step up in a critical shortage situation.
🔒 Potential Impact + source link
Subscribe to unlock the impact analysis and original source for every story.
More from HR & Workplace
- CRED's Kunal Shah to Run WhatsApp Globally as Meta Pumps ₹8,550 Crore Into His Startup
- Naukri Founder Says His AI Startup Bets Have More Than Doubled in Value
- Axis Bank Hires McKinsey Veteran to Lead AI Push Across the Entire Bank
- Walmart Ordered to Pay $23 Million After Worker Was Fired for Reporting Harassment